Dr Clare Allen
MBBS (Oxford)
GMC: 3108389
- MBBS — University of Oxford (1985)
- GMC Specialist Register — Clinical Radiology (GMC 3108389)
- UK Research Paper of the Year
A UK leader in prostate cancer care
Clare qualified from Oxford and is the uro-radiology lead consultant at University College London. She has pioneered the use of mpMRI (multiparametric magnetic resonance imaging) for prostate cancer since 2000 and has led the establishment of reporting standards for prostate cancer imaging in the UK. She was lead radiologist on the Promise Trial which proved the efficacy of mpMRI for prostate cancer globally.
In addition to having an interest in uro-oncology, Dr Allen has a well-developed clinical practice in dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) in the prostate and is leading a team of medical physicists in further defining the role of multi-sequence MRI (magnetic resonance imaging) in diagnostic utility of prostate cancer
Professional Qualifications
- MBBS, University of Oxford – 1985
Professional Affiliations
- General Medical Council
Current Appointment
- University College Hospitals, London
- Princess Grace Hospital, London
- King Edward VII’s Hospital, London
- The London Clinic, London
Awards and Distinctions
- UK Research Paper of the Year
Research and publications
- MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis. New England Journal of Medicine. 2018. https://doi.org/10.1056/NEJMoa1801993
- Biparametric vs Multiparametric MRI for Prostate Cancer Diagnosis: The PRIME Diagnostic Clinical Trial. JAMA. 2025. https://doi.org/10.1001/jama.2025.13722
- PRECISE Version 2: Updated Recommendations for Reporting Prostate Magnetic Resonance Imaging in Patients on Active Surveillance for Prostate Cancer. European Urology. 2024. https://doi.org/10.1016/j.eururo.2024.03.014
- Prostate Imaging Quality (PI-QUAL): A New Quality Control Scoring System for Multiparametric Magnetic Resonance Imaging of the Prostate from the PRECISION Trial. European Urology Oncology. 2020. https://doi.org/10.1016/j.euo.2020.06.007
- Global Variation in Magnetic Resonance Imaging Quality of the Prostate. Radiology. 2023. https://doi.org/10.1148/radiol.231130
- Quality Checkpoints in the MRI-directed Prostate Cancer Diagnostic Pathway. Nature Reviews Urology. 2022. https://doi.org/10.1038/s41585-022-00648-4
- Multiparametric MRI for Prostate Cancer Diagnosis: Current Status and Future Directions. Nature Reviews Urology. 2019. https://doi.org/10.1038/s41585-019-0212-4
- Prostate MRI Quality: A Critical Review of the Last 5 Years and the Role of the PI-QUAL Score. British Journal of Radiology. 2021. https://doi.org/10.1259/bjr.20210415
- Imaging Quality and Prostate MR: It Is Time to Improve. British Journal of Radiology. 2020. https://doi.org/10.1259/bjr.20200934
- A Multicentre Analysis of the Detection of Clinically Significant Prostate Cancer Following Transperineal Image-fusion Targeted and Nontargeted Systematic Prostate Biopsy in Men at Risk. European Urology Oncology. 2019. https://doi.org/10.1016/j.euo.2019.03.005
Learn more about Focal Therapy and Prostate Cancer
Prostate Cancer Survey: 93% of Men Had Never Heard of Focal Therapy
How Accurate Is a Urine Test for Prostate Cancer — and Can It Replace PSA or MRI?
Is Testosterone Replacement Therapy Safe After Prostate Cancer Treatment?
Any questions?
If you’ve got any questions about your prostate cancer diagnosis or want to know more about HIFU or NanoKnife, don’t hesitate to get in touch with our friendly, knowledgeable team.
Contact the team
Subscribe to our newsletter
Get expert advice & the latest prostate cancer research - straight to your inbox.
